SCHEMBL475644

SCHEMBL475644

C=C(C(=O)O)c1c(Cc2cc(C)cc(C(C)(C)C)c2O)cc(C)cc1C(C)(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 2/20 0.65
CYP2C9 P11712 4/20 0.63
CYP2C19 P33261 4/20 0.63
HIF1A Q16665 4/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
CYP2D6 P10635 3/20 0.57
HSD17B10 Q99714 1/20 0.57
ALDH1A1 P00352 3/20 0.45
CA2 P00918 2/20 0.45
POLB P06746 1/20 0.45
TYR P14679 1/20 0.45
GLRA3 O75311 1/20 0.41
GLRB P48167 1/20 0.41
AMY1A P0DUB6 1/20 0.36
GABBR2 O75899 1/20 0.35
GABBR1 Q9UBS5 1/20 0.35
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31049994 1.00 HSPA5 (0.65) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL25367107 0.92 HSPA5 (0.59) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL19732825 0.89 HSPA5 (0.50) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
Phenol SCHEMBL31296057 0.88 HSPA5 (0.50) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL275966 0.87 SMN1; SMN2 (0.50) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL3359612 0.87 HSPA5 (0.55) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL3353514 0.86 HSPA5 (0.45) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL20608349 0.83 HSPA5 (0.43) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
Acetic Acid SCHEMBL8927282 0.82 HSPA5 (0.83) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL2698990 0.82 CYP2C9 (0.63) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 896 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4455241-A1 CHEMICAL-RESISTANT REACTIVE PRESSURE SENSITIVE ADHESIVE TAPE TESA SE (DE) 2024-10-30 EP claimed
CN-117003946-A Hindered phenol grafted modified polypropylene and preparation method and application thereof 天津大学 2023-11-07 CN claimed
CN-113583320-B Crosslinkable polyolefin composition, preparation method and application thereof, crosslinked polyolefin and application thereof 国家能源投资集团有限责任公司 2023-09-05 CN claimed
EP-3331945-B1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC GLOBAL TECHNOLOGIES BV (NL) 2020-10-07 EP claimed
US-20180223075-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-08-09 US claimed
EP-3331945-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC Global Technologies B.V. (NL) 2018-06-13 EP claimed
EP-3169423-B1 PROCESS FOR PREPARING POLYALKENAMERS FOR PACKAGING APPLICATIONS EVONIK DEGUSSA GMBH (DE) 2018-01-03 EP claimed
WO-2017021124-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-02-09 WO claimed
EP-2213368-B1 Packaging body SUMITOMO CHEMICAL CO (JP) 2013-05-01 EP claimed
EP-2172512-B1 Granular stabilizer for polymer and production process thereof SUMITOMO CHEMICAL CO (JP) 2013-04-03 EP claimed
EP-0534661-B1 Production of thermoplastic resin having high impact resistance SUMITOMO CHEMICAL CO (JP) 1997-01-15 EP claimed
EP-0500323-B1 Production of bisphenol monoester SUMITOMO CHEMICAL CO (JP) 1997-01-15 EP claimed
EP-0416321-B1 Crystalline polyolefin composition CHISSO CORP (JP) 1994-11-09 EP claimed
EP-0335815-B1 Gel prevention in polymers GOODYEAR TIRE & RUBBER (US) 1994-03-09 EP claimed
EP-0209679-B1 FLAME RETARDANT POLYOLEFIN RESIN COMPOSITION Chisso Corporation (JP) 1991-10-23 EP claimed
EP-0128739-B1 METHOD OF MANUFACTURING A HOMOPOLYMER OR COPOLYMER OF TRIOXANE POLYPLASTICS CO. LTD. (JP) 1989-07-26 EP claimed
EP-0129369-B1 METHOD OF MANUFACTURING A COPOLYMER OF TRIOXANE POLYPLASTICS CO. LTD. (JP) 1988-09-14 EP claimed
EP-0079806-B1 STABILIZED POLYMERS AND THEIR PRODUCTION AND STABILIZERS THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-05-07 EP claimed
US-4579935-A STEREO-HINDERING PHENOLS TO MONOMER MIXTURE; LEWIS ACID CATALYSTS OR COMPLEXES POLYPLASTICS CO., LTD. (JP) 1986-04-01 US claimed
US-4547565-A ADDING A STERICALLY HINDERED PHENOL TO MONOMERS, CATION-ACTIVE CATALYST POLYPLASTICS COMPANY, LTD. (JP) 1985-10-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180223075-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS AQP1, POLI, AQP3 HSPA5 1820/4885CYP2C9 1642/4885CYP2C19 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.